GO:0010898 positive regulation of triglyceride catabolic process: Lipid Catabolism Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0010898 describes any process that increases the frequency, rate, or extent of triglyceride breakdown, a central node in energy homeostasis.
• Lipolysis in adipose tissue is the best-characterized mechanism for positive regulation of triglyceride catabolism, releasing free fatty acids and glycerol.
• Key regulators include lipases such as PNPLA2 (ATGL), LIPE (HSL), and LPL, as well as hormonal signals like insulin and ANGPTL proteins [1,6].
• Dysregulation of triglyceride catabolism contributes to nonalcoholic fatty liver disease, insulin resistance, and coronary artery disease [5,8].
• CRISPR knockout, point-mutation, and overexpression models are essential to dissect causal roles of genes in this process.
• The triglyceride-glucose index, a surrogate for triglyceride metabolism, correlates with coronary artery disease severity across glucose metabolism states.
Description
Triglycerides are the primary storage form of energy in mammals, and their controlled breakdown is essential for maintaining metabolic flexibility. The Gene Ontology term GO:0010898, positive regulation of triglyceride catabolic process, captures the regulatory events that enhance the hydrolysis of triglycerides into free fatty acids and glycerol. This process is critical in adipose tissue, liver, and muscle, where it supplies energy substrates and signaling lipids. Cho et al. (2023) emphasize that adipose tissue lipid metabolism, particularly lipolysis, is a tightly regulated process that responds to nutritional and hormonal cues. Understanding how this process is positively regulated has direct implications for obesity, type 2 diabetes, and cardiovascular disease. At the molecular level, positive regulation of triglyceride catabolism involves the activation of lipases, the recruitment of coactivators, and the modulation of signaling pathways that converge on lipid droplets. For example, insulin suppresses lipolysis, whereas catecholamines and natriuretic peptides stimulate it. The interplay between these signals determines the rate of triglyceride breakdown and the release of fatty acids into circulation. Disruptions in this regulatory network can lead to ectopic lipid accumulation and lipotoxicity, which are hallmarks of metabolic disorders. Researchers studying GO:0010898 are interested in identifying the genes and pathways that enhance triglyceride catabolism, as these represent potential therapeutic targets. Recent studies have linked mutations in metabolism genes to chronic liver disease, highlighting the importance of this process in human pathology. Moreover, the triglyceride-glucose index, a composite marker of triglyceride metabolism and glucose homeostasis, has been associated with coronary artery disease severity. Thus, a detailed understanding of positive regulation of triglyceride catabolic process is both biologically and clinically relevant.
positive regulation of triglyceride catabolic process At A Glance
| GO ID | GO:0010898 |
|---|---|
| GO term | positive regulation of triglyceride catabolic process |
| Ontology | biological_process |
| Synonym | positive regulation of triacylglycerol catabolic process |
| Major function | Enhances the breakdown of triglycerides into free fatty acids and glycerol |
| Related processes | Lipolysis, fatty acid oxidation, energy homeostasis |
| Key enzymes | PNPLA2 (ATGL), LIPE (HSL), LPL, MGLL |
| Regulatory signals | Catecholamines, insulin, natriuretic peptides, ANGPTL proteins |
What Is GO:0010898?
GO:0010898, positive regulation of triglyceride catabolic process, is defined as any process that increases the frequency, rate, or extent of the chemical reactions and pathways resulting in the breakdown of triglyceride. In simpler terms, it encompasses all molecular events that accelerate the hydrolysis of triglycerides into glycerol and free fatty acids. This regulation can occur at multiple levels, including enzyme activation, transcriptional control, and post-translational modifications. The term is a child of positive regulation of lipid catabolic process and is synonymous with positive regulation of triacylglycerol catabolic process.
Why Is positive regulation of triglyceride catabolic process Important in Cell Biology?
Positive regulation of triglyceride catabolic process is fundamental to energy balance and metabolic health. It ensures that stored fat can be mobilized during fasting or exercise, providing substrates for ATP production. When this process is impaired, triglycerides accumulate in tissues, leading to lipotoxicity, insulin resistance, and organ dysfunction. Conversely, excessive activation can cause uncontrolled fatty acid release, contributing to hypertriglyceridemia and cardiovascular risk. Therefore, understanding the molecular players and regulatory mechanisms of this process is essential for developing therapies for metabolic diseases.
• Maintains energy homeostasis by mobilizing stored triglycerides during fasting.
• Provides free fatty acids for beta-oxidation and glycerol for gluconeogenesis.
• Dysregulation leads to nonalcoholic fatty liver disease and steatohepatitis.
• Implicated in insulin resistance and type 2 diabetes.
• Associated with coronary artery disease severity via triglyceride-glucose index.
• Somatic mutations in metabolism genes, including those in lipid pathways, are found in chronic liver disease.
• Dietary excess regulates intestinal lipid absorption and surface area through PPARα, linking nutrient status to triglyceride metabolism.
• ANGPTL3 modulates triglyceride regulation and glucose homeostasis, affecting diabetes risk.
• APOB polymorphisms influence lipid metabolism and hepatitis C virus infection.
• Glycerol kinase drives hepatic de novo lipogenesis and triglyceride synthesis, counterbalancing catabolism.
What Happens During positive regulation of triglyceride catabolic process?
Initiation of Lipolysis at the Lipid Droplet
In simple terms: Fat droplets inside cells are coated with proteins that must be unlocked to start fat breakdown.
The first step in triglyceride catabolism is the recruitment of lipases to the surface of lipid droplets. PNPLA2 (ATGL) catalyzes the initial hydrolysis of triglyceride to diacylglycerol, and its activity is positively regulated by coactivators such as ABHD5 (CGI-58). This step is rate-limiting and is tightly controlled by hormonal signals. Cho et al. (2023) describe how adipose tissue lipolysis is initiated by the activation of ATGL and its translocation to lipid droplets.
Amplification by Hormone-Sensitive Lipase
In simple terms: A second enzyme takes over to further break down the intermediate fats.
Following the action of ATGL, LIPE (hormone-sensitive lipase, HSL) hydrolyzes diacylglycerol to monoacylglycerol. HSL is activated by phosphorylation via protein kinase A (PKA) in response to catecholamines. This phosphorylation increases HSL activity and promotes its translocation to lipid droplets. The coordinated action of ATGL and HSL ensures efficient breakdown of triglycerides into free fatty acids and glycerol.
Final Hydrolysis by Monoglyceride Lipase
In simple terms: The last enzyme completes the breakdown of the remaining fat molecule.
MGLL (monoglyceride lipase) catalyzes the final step of lipolysis, converting monoacylglycerol to glycerol and a free fatty acid. This enzyme is constitutively active and ensures that the products of lipolysis are released into the cytoplasm for further metabolism or export. The complete hydrolysis of triglyceride yields three free fatty acids and one glycerol molecule, which can enter circulation or be used locally for energy production.
Hormonal and Nutritional Regulation
In simple terms: Hormones like insulin and adrenaline tell the cell whether to store or burn fat.
Positive regulation of triglyceride catabolism is controlled by opposing hormonal signals. Insulin suppresses lipolysis by activating phosphodiesterase 3B (PDE3B), which lowers cAMP levels and reduces PKA activity. In contrast, catecholamines, glucagon, and natriuretic peptides stimulate lipolysis by increasing cAMP and activating PKA. Additionally, ANGPTL proteins modulate lipoprotein lipase (LPL) activity, thereby affecting triglyceride hydrolysis in circulation. This hormonal integration ensures that triglyceride breakdown matches the organism's energy needs.
Transcriptional and Post-translational Control
In simple terms: Cells can make more or less of the fat-breaking enzymes over time.
Long-term regulation of triglyceride catabolism involves changes in gene expression. For example, PPARα activation by dietary excess regulates intestinal lipid absorption and surface area, indirectly influencing triglyceride metabolism. Post-translational modifications, such as phosphorylation and ubiquitination, also modulate the stability and activity of lipases. These layers of regulation allow fine-tuning of triglyceride catabolism in response to chronic nutritional states.
Key Genes Involved in GO:0010898 positive regulation of triglyceride catabolic process
The following genes and proteins are central to the positive regulation of triglyceride catabolic process, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PNPLA2 (ATGL) | Catalyzes the initial step of triglyceride hydrolysis | Rate-limiting enzyme; target for obesity and NAFLD studies |
| LIPE (HSL) | Hydrolyzes diacylglycerol to monoacylglycerol | Regulated by PKA; key node in hormonal control of lipolysis |
| MGLL | Hydrolyzes monoacylglycerol to glycerol and fatty acid | Final step of lipolysis; potential drug target |
| LPL | Hydrolyzes triglycerides in circulating lipoproteins | Regulated by ANGPTL proteins; linked to hypertriglyceridemia |
| ABHD5 (CGI-58) | Coactivator of ATGL | Mutations cause Chanarin-Dorfman syndrome |
| PLIN1 | Coats lipid droplets; regulates lipase access | Phosphorylation by PKA promotes lipolysis |
| ANGPTL3 | Inhibits LPL activity | Modulates triglyceride and glucose homeostasis |
| ANGPTL4 | Inhibits LPL activity | Responds to nutritional status |
| APOB | Structural component of lipoproteins | Polymorphisms affect lipid metabolism and HCV infection |
| PPARα | Transcription factor regulating lipid metabolism | Dietary excess regulates intestinal absorption via PPARα |
| GK (Glycerol kinase) | Phosphorylates glycerol for further metabolism | Drives hepatic de novo lipogenesis and triglyceride synthesis |
| SREBP-1c | Transcription factor for lipogenic genes | Upregulated by glycerol kinase; promotes DGAT1/2 expression |
| DGAT1/2 | Catalyze the final step of triglyceride synthesis | Counterbalance catabolism; targets for NAFLD |
| INSR | Insulin receptor; mediates insulin signaling | Suppresses lipolysis via PDE3B |
| ADRB2 | Beta-2 adrenergic receptor; mediates catecholamine signaling | Stimulates lipolysis |
| PRKACA | Catalytic subunit of PKA | Phosphorylates HSL and PLIN1 to activate lipolysis |
| PDE3B | Phosphodiesterase that degrades cAMP | Insulin-activated; reduces lipolysis |
How Is positive regulation of triglyceride catabolic process Regulated?
The positive regulation of triglyceride catabolic process is controlled by a complex network of hormonal, nutritional, and transcriptional signals. Insulin is the primary suppressor of lipolysis, acting through the PI3K-Akt pathway to activate PDE3B, which decreases cAMP and reduces PKA-mediated phosphorylation of HSL and PLIN1. In contrast, catecholamines, glucagon, and natriuretic peptides stimulate lipolysis by increasing cAMP and activating PKA. ANGPTL proteins, particularly ANGPTL3 and ANGPTL4, regulate LPL activity and thus circulating triglyceride hydrolysis. At the transcriptional level, PPARα and SREBP-1c modulate the expression of genes involved in lipid metabolism, including those that influence triglyceride catabolism [4,5]. Additionally, glycerol kinase (GK) promotes de novo lipogenesis and triglyceride synthesis, indirectly affecting the balance between synthesis and breakdown. This multilayered regulation ensures that triglyceride catabolism is appropriately tuned to energy demand and nutrient availability.
positive regulation of triglyceride catabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PNPLA2 | Neutral lipid storage disease with myopathy | Knockout mouse or patient-derived iPSCs |
| LIPE | Familial partial lipodystrophy | Point-mutation knock-in in mice |
| ANGPTL3 | Hypertriglyceridemia, coronary artery disease | Overexpression and knockout models |
| APOB | Hepatitis C virus infection, dyslipidemia | Knock-in of polymorphism in hepatoma cells |
| GK | NAFLD, hepatic steatosis | Liver-specific knockout or overexpression |
Nonalcoholic Fatty Liver Disease (NAFLD)
Impaired positive regulation of triglyceride catabolism contributes to hepatic steatosis, a hallmark of NAFLD. Glycerol kinase drives hepatic de novo lipogenesis and triglyceride synthesis by activating SREBP-1c and upregulating DGAT1/2, which can overwhelm catabolic pathways. Somatic mutations in metabolism genes, including those involved in lipid handling, have been identified in chronic liver disease, suggesting that dysregulated triglyceride catabolism may be a driver of disease progression.
Cardiovascular Disease and Hypertriglyceridemia
The triglyceride-glucose index, a surrogate marker of triglyceride metabolism, is associated with coronary artery disease severity across different glucose metabolism states. ANGPTL3, a key regulator of triglyceride catabolism, modulates triglyceride and glucose homeostasis, and its inhibition is a therapeutic strategy for hypertriglyceridemia. Thus, positive regulation of triglyceride catabolism is directly relevant to cardiovascular risk assessment and treatment.
Type 2 Diabetes and Insulin Resistance
Insulin resistance impairs the suppression of lipolysis, leading to elevated circulating free fatty acids and ectopic lipid accumulation, which exacerbate glucose intolerance. ANGPTL3 also affects glucose homeostasis and diabetes risk. Intensive insulin therapy has been shown to increase sex hormone-binding globulin in newly diagnosed type 2 diabetic patients, reflecting improved metabolic control that may involve changes in triglyceride catabolism.
Infectious Disease and Lipid Metabolism
APOB codon 4311 polymorphism is associated with hepatitis C virus infection through altered lipid metabolism, highlighting a link between triglyceride catabolism and viral pathogenesis. This suggests that genetic variation in lipid handling pathways can influence susceptibility to infectious diseases.
From positive regulation of triglyceride catabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of PNPLA2 impair triglyceride catabolism? | CRISPR knockout in adipocytes or hepatocytes |
| Does a specific point mutation in LIPE affect lipolysis? | Point-mutation knock-in in cell lines |
| Does overexpression of ANGPTL3 reduce LPL activity? | Overexpression cell model |
| Does a tagged version of ATGL localize to lipid droplets? | Tagged knock-in for imaging |
| Does PPARα activation enhance intestinal lipid absorption? | Knockout and overexpression in intestinal organoids |
| Does glycerol kinase promote de novo lipogenesis? | Liver-specific knockout or overexpression |
How to Study the positive regulation of triglyceride catabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Glycerol release assay | Rate of triglyceride hydrolysis | Screening for positive regulators of lipolysis |
| CRISPR knockout screen | Genes required for or limiting triglyceride catabolism | Discovery of novel regulators |
| RNA-seq | Transcriptional changes in lipid metabolism genes | Assessing PPARα and SREBP-1c target genes [4,5] |
| Western blot | Protein levels and phosphorylation of lipases | Validating HSL activation |
| Immunofluorescence | Localization of lipases to lipid droplets | Confirming ATGL translocation |
| Lipidomics | Quantification of triglyceride species | Measuring changes in lipid composition |
| Seahorse assay | Fatty acid oxidation rate | Linking catabolism to energy production |
| Triglyceride-glucose index calculation | Composite marker of triglyceride and glucose metabolism | Clinical association studies |
Lipolysis Assays
Direct measurement of glycerol and free fatty acid release from cultured adipocytes or tissue explants is the gold standard for assessing triglyceride catabolic rate. These assays can be coupled with pharmacological inhibitors or genetic perturbations to identify positive regulators.
CRISPR Screening
Genome-wide CRISPR knockout or activation screens can identify genes whose loss or gain enhances triglyceride catabolism. Such screens have been instrumental in uncovering novel regulators of lipid metabolism.
Transcriptomics and Proteomics
RNA-seq and quantitative proteomics can reveal changes in gene expression and protein abundance that accompany altered triglyceride catabolism. For example, PPARα target genes are induced by dietary excess, reflecting transcriptional regulation.
Imaging of Lipid Droplets
Fluorescence microscopy with lipid droplet dyes (e.g., BODIPY) and tagged lipases allows visualization of lipid droplet dynamics and lipase recruitment in live cells. This approach can confirm the localization of ATGL and HSL to lipid droplets upon stimulation.
How CRISPR Can Be Used to Study GO:0010898 positive regulation of triglyceride catabolic process
Knockout
CRISPR knockout of genes such as PNPLA2, LIPE, or MGLL can abolish or reduce triglyceride catabolism, providing causal evidence for their role. Knockout models are also useful for identifying compensatory pathways.
Point Mutation
Introducing specific point mutations (e.g., in LIPE phosphorylation sites) via CRISPR can dissect the contribution of individual residues to lipase activation and triglyceride catabolism.
Knock-in
Knock-in of tagged versions of lipases (e.g., GFP-ATGL) allows real-time imaging of protein localization and dynamics during lipolysis. Knock-in of disease-associated polymorphisms (e.g., APOB) can model their impact on lipid metabolism.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression can increase the levels of positive regulators such as ATGL or HSL, leading to enhanced triglyceride catabolism. This approach is useful for gain-of-function studies.
How EDITGENE Supports positive regulation of triglyceride catabolic process Research
Researchers studying positive regulation of triglyceride catabolic process-related genes often need to determine whether a candidate gene is causally involved in enhancing lipid breakdown. This requires precise genetic manipulation, which can be achieved through CRISPR-based knockout, point mutation, knock-in, or overexpression models. EDITGENE provides end-to-end services to generate such models and to screen for novel regulators using CRISPR libraries and bioinformatics.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of triglyceride catabolic process research.
Frequently Asked Questions About positive regulation of triglyceride catabolic process
What is GO:0010898?
GO:0010898 is the Gene Ontology term for positive regulation of triglyceride catabolic process, which includes any process that increases the breakdown of triglycerides into free fatty acids and glycerol.
What genes are involved in positive regulation of triglyceride catabolic process?
Key genes include PNPLA2 (ATGL), LIPE (HSL), MGLL, LPL, ABHD5, PLIN1, ANGPTL3, ANGPTL4, APOB, PPARα, and GK [1,3,4,5,6].
How is triglyceride catabolism regulated?
It is regulated by hormones such as insulin (inhibitory) and catecholamines (stimulatory), as well as by transcriptional factors like PPARα and SREBP-1c [1,4,5].
What diseases are associated with impaired triglyceride catabolism?
Impaired catabolism is linked to nonalcoholic fatty liver disease, hypertriglyceridemia, coronary artery disease, and type 2 diabetes [5,6,8].
What is the role of ANGPTL3 in triglyceride metabolism?
ANGPTL3 inhibits lipoprotein lipase, thereby reducing triglyceride hydrolysis, and its modulation affects glucose homeostasis and diabetes risk.
How can CRISPR be used to study triglyceride catabolism?
CRISPR knockout, point mutation, knock-in, and overexpression models allow researchers to test the causal role of specific genes in triglyceride breakdown [1,2].
What is the triglyceride-glucose index?
The triglyceride-glucose index is a composite marker of triglyceride and glucose metabolism that correlates with coronary artery disease severity.
Which enzyme initiates triglyceride hydrolysis?
PNPLA2 (ATGL) catalyzes the initial step of triglyceride hydrolysis, converting triglyceride to diacylglycerol.
How does insulin affect lipolysis?
Insulin suppresses lipolysis by activating PDE3B, which lowers cAMP and reduces PKA-mediated activation of HSL and PLIN1.
What experimental models are used to study positive regulation of triglyceride catabolic process?
Common models include CRISPR-engineered cell lines, knockout mice, and patient-derived organoids, coupled with lipolysis assays and lipidomics [1,5].
Conclusion
Positive regulation of triglyceride catabolic process (GO:0010898) is a critical biological process that governs energy mobilization and metabolic health. The coordinated action of lipases, coactivators, and hormonal signals ensures that triglycerides are broken down appropriately in response to nutritional and hormonal cues. Dysregulation of this process contributes to prevalent metabolic diseases, including NAFLD, cardiovascular disease, and diabetes. Continued research using advanced CRISPR models and multi-omics approaches will further elucidate the regulatory networks and identify therapeutic targets.
References
- 1. Cho CH et al.. 2023. Adipose tissue lipid metabolism: lipolysis.. Curr Opin Genet Dev 83:102114 PMID: 37738733
- 2. Ng SWK et al.. 2021. Convergent somatic mutations in metabolism genes in chronic liver disease.. Nature 598(7881):473-478 PMID: 34646017
- 3. Harada R et al.. 2018. APOB codon 4311 polymorphism is associated with hepatitis C virus infection through altered lipid metabolism.. BMC Gastroenterol 18(1):24 PMID: 29382324
- 4. Stojanović O et al.. 2021. Dietary excess regulates absorption and surface of gut epithelium through intestinal PPARα.. Nat Commun 12(1):7031 PMID: 34857752
- 5. Ouyang S et al.. 2024. Glycerol Kinase Drives Hepatic de novo Lipogenesis and Triglyceride Synthesis in Nonalcoholic Fatty Liver by Activating SREBP-1c Transcription, Upregulating DGAT1/2 Expression, and Promoting Glycerol Metabolism.. Adv Sci (Weinh) 11(46):e2401311 PMID: 39418169
- 6. Christopoulou E et al.. 2019. Effects of Angiopoietin-Like 3 on Triglyceride Regulation, Glucose Homeostasis, and Diabetes.. Dis Markers 2019:6578327 PMID: 30944669
- 7. Tong G et al.. 2014. Intensive insulin therapy increases sex hormone-binding globulin in newly diagnosed type 2 diabetic patients.. Eur J Endocrinol 170(2):237-45 PMID: 24194532
- 8. Zhao S et al.. 2024. Comprehensive analysis of the association between triglyceride-glucose index and coronary artery disease severity across different glucose metabolism states: a large-scale cross-sectional study from an Asian cohort.. Cardiovasc Diabetol 23(1):251 PMID: 39003471
